Successful early-phase CNS development requires careful planning, specialized expertise, and the right infrastructure from the start. With extensive experience conducting Phase 1 studies, including first-in-human trials, and purpose-built CNS clinical research units with cutting-edge technology and modern facilities, Clinilabs provides the foundation sponsors need to move promising therapies forward with confidence.
Download the fact sheet for a closer look at how Clinilabs supports Phase 1 CNS clinical trials through:
- Purpose-built clinical research units in the New York-New Jersey area
- Extensive early-phase expertise, including studies such as single ascending dose, multiple ascending dose, food effect, and drug-drug interaction trials
- Specialized CNS assessments including polysomnography, quantitative electroencephalography, cerebrospinal fluid sampling, cognitive testing, and psychiatric rating scales
- Advanced electronic data systems and customizable eSource and electronic data capture platforms
- Access to a large and diverse volunteer database of more than 80,000 potential candidates
When you need a partner experienced in Phase 1 CNS clinical trials, your pathway to CNS approval starts with Clinilabs.
